Identification of MiRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2016 Jun 29

PMID 27350400

Citations 12

Authors

Minglei Liu

Kangru Zhu

Xinmei Qian

Wei Li

Affiliations

Soon will be listed here.

Abstract

BACKGROUND Nasopharyngeal carcinoma (NPC) is a common malignancy in South-East Asia. NPC is characterized by distant metastasis and poor prognosis. The pathophysiological mechanism of nasopharyngeal carcinoma is unknown. This study aimed to identify the crucial miRNAs in nasopharyngeal carcinoma and their target genes, and to discover the potential mechanism of nasopharyngeal carcinoma development. MATERIAL AND METHODS Microarray expression profiling of miRNA and mRNA from the Gene Expression Omnibus database was downloaded, and we performed a significance analysis of differential expression. An interaction network of miRNAs and target genes was constructed. The underlying function of differentially expressed genes was predicted through Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses. To validate the microarray analysis data, significantly different expression levels of miRNAs and target genes were validated by quantitative real-time polymerase chain reaction. RESULTS We identified 27 differentially expressed miRNAs and 982 differentially expressed mRNAs between NPC and normal control tissues. 12 miRNAs and 547 mRNAs were up-regulated and 15 miRNAs and 435 mRNAs were down-regulated in NPC samples. We found a total of 1185 negative correlation pairs between miRNA and mRNA. Differentially expressed target genes were significantly enriched in pathways in cancer, cell cycle, and cytokine-cytokine receptor interaction signaling pathways. Significantly differentially expressed miRNAs and genes, such as hsa-miR-205, hsa-miR-18b, hsa-miR-632, hsa-miR-130a, hsa-miR-34b, PIGR, SMPD3, CD22, DTX4, and CDC6, may play essential roles in the development of nasopharyngeal carcinoma. CONCLUSIONS hsa-miR-205, hsa-miR-18b, hsa-miR-632, hsa-miR-130a, and hsa-miR-34b may be related to the development of nasopharyngeal carcinoma by regulating the genes involved in pathways in cancer and cell cycle signaling pathways.

Citing Articles

Deltex E3 ubiquitin ligase 4 promotes thyroid cancer progression through stearoyl-CoA desaturase 1.

Cui Y, Luo J, Bai N, Yu Z Funct Integr Genomics. 2023; 23(3):280.

PMID: 37612343 DOI: 10.1007/s10142-023-01215-9.

The Expression of miR-205 in Prostate Carcinoma and the Relationship with Prognosis in Patients.

Guo Z, Lu X, Yang F, Qin L, Yang N, Cai P Comput Math Methods Med. 2022; 2022:1784791.

PMID: 36081431 PMC: 9448532. DOI: 10.1155/2022/1784791.

Meta-Analysis illustrates possible role of lipopolysaccharide (LPS)-induced tissue injury in nasopharyngeal carcinoma (NPC) pathogenesis.

Allen D, Aljabban J, Silverman D, McDermott S, Wanner R, Rohr M PLoS One. 2021; 16(10):e0258187.

PMID: 34648530 PMC: 8516236. DOI: 10.1371/journal.pone.0258187.

Functions and Molecular Mechanisms of Deltex Family Ubiquitin E3 Ligases in Development and Disease.

Wang L, Sun X, He J, Liu Z Front Cell Dev Biol. 2021; 9:706997.

PMID: 34513839 PMC: 8424196. DOI: 10.3389/fcell.2021.706997.

Deltex3 inhibits Epithelial Mesenchymal Transition in Papillary Thyroid Carcinoma via promoting ubiquitination of XRCC5 to regulate the AKT signal pathway.

Wang L, Huang Y, Liu C, Guo M, Ma Z, He J J Cancer. 2021; 12(3):860-873.

PMID: 33403043 PMC: 7778541. DOI: 10.7150/jca.48141.

References

Hsu W, Chen J, Chien Y, Liu M, You S, Hsu M . Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan. Cancer Epidemiol Biomarkers Prev. 2009; 18(4):1218-26. DOI: 10.1158/1055-9965.EPI-08-1175. View

Tang J, Yu Z, Liu T, Lin Z, Wang Y, Yang L . Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma. Asian Pac J Cancer Prev. 2014; 15(18):7575-81. DOI: 10.7314/apjcp.2014.15.18.7575. View

Tascedda F, Malagoli D, Accorsi A, Rigillo G, Blom J, Ottaviani E . Molluscs as models for translational medicine. Med Sci Monit Basic Res. 2015; 21:96-9. PMC: 4427025. DOI: 10.12659/MSMBR.894221. View

Luo Z, Zhang L, Li Z, Li X, Li G, Yu H . An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma. BMC Med Genomics. 2012; 5:3. PMC: 3293045. DOI: 10.1186/1755-8794-5-3. View

Min W, Wang B, Li J, Han J, Zhao Y, Su W . The expression and significance of five types of miRNAs in breast cancer. Med Sci Monit Basic Res. 2014; 20:97-104. PMC: 4117676. DOI: 10.12659/MSMBR.891246. View

Li L, Wu J, Sima X, Bai P, Deng W, Deng X . Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma. Tumour Biol. 2013; 34(3):1919-23. DOI: 10.1007/s13277-013-0736-9. View

Qu J, Yi H, Ye X, Li L, Zhu J, Xiao T . MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway. Oncotarget. 2015; 6(29):28341-56. PMC: 4695064. DOI: 10.18632/oncotarget.5117. View

Pan X, Peng G, Liu S, Sun Z, Zou Z, Wu G . MicroRNA-4649-3p inhibits cell proliferation by targeting protein tyrosine phosphatase SHP-1 in nasopharyngeal carcinoma cells. Int J Mol Med. 2015; 36(2):559-64. DOI: 10.3892/ijmm.2015.2245. View

Zhao L, Tang M, Hu Z, Yan B, Pi W, Li Z . miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma. Oncotarget. 2015; 6(18):15995-6018. PMC: 4599252. DOI: 10.18632/oncotarget.4138. View

10.

Tsao S, Yip Y, Tsang C, Pang P, Lau V, Zhang G . Etiological factors of nasopharyngeal carcinoma. Oral Oncol. 2014; 50(5):330-8. DOI: 10.1016/j.oraloncology.2014.02.006. View

11.

Diboun I, Wernisch L, Orengo C, Koltzenburg M . Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics. 2006; 7:252. PMC: 1618401. DOI: 10.1186/1471-2164-7-252. View

12.

Feng C, Lu X, Luo D, Li H, Guo J . Knockdown of Cdc6 inhibits proliferation of tongue squamous cell carcinoma Tca8113 cells. Technol Cancer Res Treat. 2012; 12(2):173-81. DOI: 10.7785/tcrt.2012.500302. View

13.

Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

14.

Sang Y, Chen M, Luo D, Zhang R, Wang L, Li M . TEL2 suppresses metastasis by down-regulating SERPINE1 in nasopharyngeal carcinoma. Oncotarget. 2015; 6(30):29240-53. PMC: 4745723. DOI: 10.18632/oncotarget.5074. View

15.

Jia W, Qin H . Non-viral environmental risk factors for nasopharyngeal carcinoma: a systematic review. Semin Cancer Biol. 2012; 22(2):117-26. DOI: 10.1016/j.semcancer.2012.01.009. View

16.

Zhang X, Xiao D, Wang Z, Zou Y, Huang L, Lin W . MicroRNA-26a/b regulate DNA replication licensing, tumorigenesis, and prognosis by targeting CDC6 in lung cancer. Mol Cancer Res. 2014; 12(11):1535-46. DOI: 10.1158/1541-7786.MCR-13-0641. View

17.

Ohtsuka M, Ling H, Doki Y, Mori M, Calin G . MicroRNA Processing and Human Cancer. J Clin Med. 2015; 4(8):1651-67. PMC: 4555082. DOI: 10.3390/jcm4081651. View

18.

Ren X, Zhou G, Jiang W, Sun Y, Xu Y, Li Y . Low SFRP1 Expression Correlates with Poor Prognosis and Promotes Cell Invasion by Activating the Wnt/β-Catenin Signaling Pathway in NPC. Cancer Prev Res (Phila). 2015; 8(10):968-77. DOI: 10.1158/1940-6207.CAPR-14-0369. View

19.

Radtke F, Wilson A, Mancini S, MacDonald H . Notch regulation of lymphocyte development and function. Nat Immunol. 2004; 5(3):247-53. DOI: 10.1038/ni1045. View

20.

Zhang X, Zhong T, Dang Y, Li Z, Li P, Chen G . Aberrant expression of CDK5 infers poor outcomes for nasopharyngeal carcinoma patients. Int J Clin Exp Pathol. 2015; 8(7):8066-74. PMC: 4555701. View